Common Stock, par value $0.001 per share
- Symbol
- TELA
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01 · 8-K
TELA Bio, Inc.
TELANASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On October 5, 2026, TELA Bio, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC stating that the Company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) and the matter is now closed.…
Company context
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Current securities
Registered securities in this filing
TELA Bio, Inc. · 8-K · Filed 2026-10-06
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On October 5, 2026, TELA Bio, Inc. (the “Company”)
received a letter from The Nasdaq Stock Market LLC stating that the Company has regained compliance with the minimum bid price requirement
for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) and the matter is now closed. The Company’s
common stock continues to be listed and traded on the Nasdaq Global Market under the trading symbol “TELA”.